January 17th, 2024
GLP-1 medications were marketed as a game changer in diabetes care and weight loss. They certainly have changed the conversations with employers as they experience a sharp increase in utilization, with the cost having a significant impact on budget. Manufacturer research has shown significant improvement in A1c control, weight loss and perhaps even cardiovascular risk. It has been touted as the wonder drug. Yet, everyone has heard of the side effects, dependence on the drug long term, off label use, and the financial impact. Listen to our panel of experts discuss how they have been able to successfully leverage these medications for the right target patient and what strategies have proven successful to reduce side effects, poor outcomes, and inappropriate use.
Obesity Medicine Physician
Population Health Pharmacist
Director of Clinical Pharmacy, AEC-Rx